Dr. Lal PathLabs records revenue of Rs498.4cr in Q2 FY22

Net margins at 19.06% was lower than 19.75% on a yoy basis and it was sharply lower than NPM of 21.63% in Jun-21 quarter.

Oct 27, 2021 04:10 IST India Infoline News Service

Dr Lal Pathlabs
Dr. Lal PathLabs, a leading diagnostic and related healthcare services provider announced its financial results for the quarter ended September 30, 2021.

The net profit of the company was up by 11.37% to Rs95cr in the quarter ended September 2021 as against Rs85.30cr during the previous quarter ended September 2020. Also, the yoy profit growth was subdued because the raw material costs spiked by 25% on a yoy basis putting pressure on profit growth. Net margins at 19.06% were lower than 19.75% on a yoy basis and it was sharply lower than NPM of 21.63% in the Jun-21 quarter.

The Sales rose 15.40% to Rs 498.40 crore in the quarter ended September 2021 as against Rs 431.90 crore during the previous quarter ended September 2020.

The stock ended at Rs3,524 down by Rs30 or 0.84% from its previous closing of Rs3,554 on the BSE. The scrip opened at Rs3,556 and has touched a high and low of Rs3,685.15 and Rs3,453.65 respectively.

The board of the company has already approved the first dividend of 60% or Rs.6 per share on par value of Rs.10. For the first half of fiscal year 2021-22, the net cash generated from operations has increased sharply by 81% at Rs282cr in the September ended first half.

Related Story

Open Free Demat Account (Rs699)
Open ZERO Brokerage Demat Account

  • 0

    Delivery Brokerage for Lifetime

  • 20

    Per order for Intraday, F&O, Currency & Commodity